Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia.

Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.

Condition
Hypoglycemia Insulinoma

Further Study Details: 

Expected Total Enrollment:  9999

The purpose of this protocol is to continue our studies of the evaluation and treatment of patients with fasting hypoglycemia due to diverse etiologies. Patients will be admitted to the Clinical Center under this protocol and undergo supervised fasting, dynamic tests of insulin secretion when appropriate, medically indicated imaging studies, and appropriate medical and surgical treatment.

Genders Eligible for Study:  Both

Criteria

Documentation of plasma glucose below 45 mg/dl is required for enrollment.

Maryland
      National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 9000 Rockville Pike,  Bethesda,  Maryland,  20892,  United States; Recruiting

Study ID Numbers:  910066; 91-DK-0066
Record last reviewed:  January 6, 2005
Last Updated:  January 31, 2005
Record first received:  November 3, 1999
ClinicalTrials.gov Identifier:  NCT00001276
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08